Glibenclamide

• Recruiting NCT NCT05426681

  Spinal Cord Injury Neuroprotection With Glyburide

  Not yet reported Francis Farhadi 12 participants Est. completion 2028-05 1 site
  Other conditions: Acute Spinal Cord Injury
  View official trial listing →
• Recruiting NCT NCT07802561

  Comparison of Metformin Versus Glyburide for Blood Sugar Control in Women With Gestational Diabetes

  Not yet reported Nishtar Medical University 92 participants Est. completion 2026-10-17 1 site
  Other conditions: Gestational Diabetes Mellitus (GDM)
  View official trial listing →
• Completed NCT NCT00035542

  A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

  Not yet reported Bristol-Myers Squibb Est. completion 2003-10 50 sites
  Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
  View official trial listing →
• Completed NCT NCT00035568

  A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

  Not yet reported Bristol-Myers Squibb Est. completion 2003-06 9 sites
  Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
  View official trial listing →
• Completed NCT NCT00046462

  Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

  Not yet reported Sanofi 240 participants Est. completion 2004-12 1 site
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00123643

  Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

  Not yet reported St. Paul Heart Clinic 36 participants Est. completion 2005-12 1 site
  Type 2 diabetes
  View official trial listing →
• Withdrawn NCT NCT00160485

  Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes

  Not yet reported Tripler Army Medical Center Est. completion 2010-06 1 site
  Other conditions: Gestational Diabetes
  View official trial listing →
• Completed NCT NCT00162175

  PPAR-COMBO With Sulfonylurea

  Not yet reported Bristol-Myers Squibb 534 participants Est. completion 2005-11 149 sites
  Other conditions: Metabolics Diabetes Nos
  View official trial listing →
• Completed NCT NCT00184821

  Ischemic Injury and Ischemic Preconditioning in Diabetes

  Radboud University Medical Center 20 participants Est. completion 2005-05 1 site
  Other conditions: Diabetes Mellitus, Insulin-Dependent, Ischemia-Reperfusion Injury
  View official trial listing →
• Completed NCT NCT00194896

  Preferred Treatment of Type 1.5 Diabetes

  Not yet reported University of Washington 64 participants Est. completion 2008-12 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00232583

  Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

  Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2011-12 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00238472

  A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion

  Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2005-06
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT00251940

  GALLANT 7 Tesaglitazar Add-on to Sulphonylurea

  Not yet reported AstraZeneca 555 participants Est. completion 2006-03 84 sites
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT00255541

  GALLANT 4 Tesaglitazar vs. Glibenclamide

  Not yet reported AstraZeneca 580 participants Est. completion 2006-12 66 sites
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT00267683

  Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

  Not yet reported Novo Nordisk A/S 9 participants Est. completion 2006-04
  Type 2 diabetes Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT00279045

  Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

  Not yet reported GlaxoSmithKline 4426 participants Est. completion 2006-06-19 490 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00286468

  Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

  Not yet reported Takeda 500 participants Est. completion 2007-06 68 sites
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Terminated NCT NCT00300105

  GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

  Not yet reported AstraZeneca 400 participants Est. completion 2006-12 42 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00313313

  A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

  Not yet reported AstraZeneca 768 participants Est. completion 2008-09 115 sites
  Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT00333723

  AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone

  Not yet reported GlaxoSmithKline 245 participants Est. completion 2003-01-06
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00347100

  Insulin Glargine in Type 2 Diabetic Patients

  Not yet reported Sanofi 387 participants 1 site
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT00371306

  Comparison of Glucovance to Insulin for Diabetes During Pregnancy

  Not yet reported Regional Obstetrical Consultants 200 participants Est. completion 2008-09 1 site
  Type 2 diabetes Other conditions: Gestational Diabetes, Pregnancy
  View official trial listing →
• Completed NCT NCT00379769

  RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes

  Not yet reported GlaxoSmithKline 4447 participants Est. completion 2008-12 446 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00388986

  A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

  Not yet reported Hoffmann-La Roche 18 participants Est. completion 2007-07 4 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00393718

  Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

  Not yet reported Novo Nordisk A/S 400 participants Est. completion 2008-05 1 site Added to GLP-1
  Type 2 diabetes Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT00417729

  Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM

  Not yet reported Taichung Veterans General Hospital 51 participants Est. completion 2009-01 1 site
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00434772

  Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers

  Not yet reported Shaare Zedek Medical Center Est. completion 2009-05 1 site
  Other conditions: Hypoglycemia
  View official trial listing →
• Completed NCT NCT00451620

  Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

  Not yet reported University of British Columbia 30 participants Est. completion 2011-09 1 site
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT00472875

  Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?

  Not yet reported King's College Hospital NHS Trust 10 participants 1 site
  Other conditions: Type 1 Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00486187

  Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

  Not yet reported Dr. Milan Gupta 103 participants Est. completion 2009-06 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00494312

  Safety Study of Pioglitazone Compared To Glyburide on Liver Function

  Not yet reported Takeda 2120 participants Est. completion 2005-06
  Other conditions: Diabetes Mellitus, Liver
  View official trial listing →
• Completed NCT NCT00515801

  Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM

  Not yet reported, Not yet reported University Hospital, Basel, Switzerland 18 participants 1 site Stand-alone
  Other conditions: Diabetes Mellitus, Type 1
  View official trial listing →
• Completed NCT NCT00521742

  Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

  Not yet reported Takeda 300 participants Est. completion 2003-01
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Terminated NCT NCT00521820

  Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

  Not yet reported Takeda 518 participants Est. completion 2003-10
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00541437

  Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

  Genovate Biotechnology Co., Ltd., 12 participants Est. completion 2007-02 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00549874

  Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes

  Not yet reported University of Michigan 27 participants Est. completion 2006-11 2 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00608179

  Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia

  Not yet reported Vanderbilt University 32 participants Est. completion 2010-12
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00610038

  Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus

  Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2011-12 1 site Stand-alone
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Status unknown NCT NCT00696982

  The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation

  Not yet reported Assaf-Harofeh Medical Center 60 participants Est. completion 2009-06 1 site Stand-alone
  Other conditions: Diabetes Mellitus, Arterial Stiffness
  View official trial listing →
• Status unknown NCT NCT00700856

  Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial

  Not yet reported Italian Society of Diabetology 3371 participants Est. completion 2018-12 61 sites
  Type 2 diabetesCardiovascular disease
  View official trial listing →
• Completed NCT NCT00734669

  Risk of Hypoglycemia in Type 2 Diabetes

  University of Giessen 12 participants Est. completion 2016-10
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00744965

  Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo

  Not yet reported University of Texas Southwestern Medical Center 395 participants Est. completion 2016-01 1 site
  Other conditions: Mild Gestational Diabetes
  View official trial listing →
• Terminated NCT NCT00759720

  Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

  Not yet reported Takeda 447 participants Est. completion 2004-12
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00770835

  Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

  Not yet reported Takeda 39 participants Est. completion 2011-05 2 sites
  Other conditions: Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT00835991

  Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed

  Not yet reported Teva Pharmaceuticals USA 60 participants Est. completion 2003-02 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00836472

  Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

  Not yet reported Teva Pharmaceuticals USA 60 participants Est. completion 2003-04 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00864734

  A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions

  Not yet reported Actavis Inc. 24 participants Est. completion 2002-11 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00865241

  A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions

  Not yet reported Actavis Inc. 36 participants Est. completion 2002-11 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00865436

  A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions

  Not yet reported Actavis Inc. 36 participants Est. completion 2004-04 1 site
  Other conditions: Healthy
  View official trial listing →
• Withdrawn NCT NCT00935363

  Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)

  Not yet reported University of California, San Francisco Est. completion 2010-04
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT00935805

  Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

  Hospital de Clinicas de Porto Alegre 124 participants Est. completion 2012-07 1 site
  Other conditions: Diabetes Mellitus, Arterial Hypertension
  View official trial listing →
• Completed NCT NCT00965991

  Metformin Compared to Glyburide in Gestational Diabetes

  Not yet reported University of New Mexico 149 participants Est. completion 2023-08 1 site
  Other conditions: Gestational Diabetes
  View official trial listing →
• Terminated NCT NCT01029795

  A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

  Not yet reported Eli Lilly and Company 38 participants Est. completion 2010-06 16 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01045590

  Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus

  Not yet reported GlaxoSmithKline 100 participants Est. completion 2006-02 4 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01068860

  To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

  Not yet reported Novartis 246 participants Est. completion 2010-08 52 sites
  Type 2 diabetesPrediabetes
  View official trial listing →
• Completed NCT NCT01107717

  Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

  Not yet reported The University of Texas Health Science Center at San Antonio 318 participants Est. completion 2023-02-03 1 site
  Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT01131182

  Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

  Not yet reported Merck Sharp & Dohme LLC 1147 participants Est. completion 2010-11-04
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01132703

  Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers

  Not yet reported Biogen 34 participants Est. completion 2010-05-07 1 site
  Cardiovascular disease Other conditions: Traumatic Brain Injury
  View official trial listing →
• Completed NCT NCT01145534

  Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes

  Not yet reported, Not yet reported Federal University of Paraíba 15 participants Est. completion 2009-10 1 site
  Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT01195259

  Malignancy Meta Analysis for BRL49653

  GlaxoSmithKline 1 participants Est. completion 2010-01
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01215331

  Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?

  Not yet reported Université de Sherbrooke 73 participants Est. completion 2016-05 1 site
  Other conditions: Gestational Diabetes Mellitus
  View official trial listing →
• Status unknown NCT NCT01242137

  Pharmacogenetic Effect on the Pharmacodynamics of Glibenclamide

  Assaf-Harofeh Medical Center 30 participants 1 site
  Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT01242215

  A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

  Not yet reported Astellas Pharma Inc 243 participants Est. completion 2012-04-25 7 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01268683

  Glyburide Advantage in Malignant Edema and Stroke Pilot

  Not yet reported, Not yet reported Remedy Pharmaceuticals, Inc. 10 participants Est. completion 2012-06-07 4 sites
  Cardiovascular disease
  View official trial listing →
• Status unknown NCT NCT01319734

  Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus

  Not yet reported Al-Neelain University 50 participants 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01329016

  Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)

  Not yet reported, Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 177 participants Est. completion 2015-02-28 4 sites
  Other conditions: Gestational Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT01340768

  Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)

  Not yet reported Merck Sharp & Dohme LLC 870 participants Est. completion 2011-09-21
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01357135

  An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)

  Merck Sharp & Dohme LLC 3453 participants Est. completion 2013-08-31
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01454154

  Glyburide (RP-1127) for Traumatic Brain Injury (TBI)

  Not yet reported Remedy Pharmaceuticals, Inc. 29 participants Est. completion 2015-02-20 4 sites
  Other conditions: Traumatic Brain Injury
  View official trial listing →
• Completed NCT NCT01456650

  R230C and C230C Variants of ABCA1 and Glyburide Response

  Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 85 participants Est. completion 2012-12 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01540396

  Gestational Diabetes Diagnostic Methods

  Not yet reported University of Pittsburgh 47 participants Est. completion 2014-12 1 site
  Other conditions: Gestational Diabetes
  View official trial listing →
• Completed NCT NCT01563120

  A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus

  Not yet reported HaEmek Medical Center, Israel 108 participants Est. completion 2014-12 1 site
  Other conditions: Gestational Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT01584232

  A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

  Not yet reported Eli Lilly and Company 361 participants Est. completion 2013-07 15 sites Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01605773

  Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes

  Not yet reported Novo Nordisk A/S 51 participants Est. completion 2003-03-13 1 site
  Type 2 diabetes Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT01697592

  Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

  Not yet reported Merck Sharp & Dohme LLC 585 participants Est. completion 2014-05-08 Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01698931

  Efficacy of Repaglinide in Subjects With Type 2 Diabetes

  Not yet reported Novo Nordisk A/S 9 participants Est. completion 2003-03-06 1 site
  Type 2 diabetes Other conditions: Diabetes
  View official trial listing →
• Completed NCT NCT01716338

  Glyburide Healthy Volunteer Study

  Not yet reported Washington University School of Medicine 21 participants Est. completion 2014-08 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT01731431

  Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes

  Not yet reported Assistance Publique - Hôpitaux de Paris 914 participants Est. completion 2017-06-02 1 site
  Other conditions: Diabetes, Gestational
  View official trial listing →
• Completed NCT NCT01733108

  A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers

  Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 29 participants Est. completion 2008-09
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01794182

  Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

  Not yet reported Remedy Pharmaceuticals, Inc. 86 participants Est. completion 2016-04-04 17 sites
  Cardiovascular disease Other conditions: Malignant Edema
  View official trial listing →
• Completed NCT NCT01798706

  Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

  Not yet reported Sanofi 350 participants Est. completion 2015-02 83 sites Added to GLP-1
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT01822548

  Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes

  Not yet reported Azienda Ospedaliero-Universitaria di Parma 64 participants Est. completion 2015-01 2 sites
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT01867502

  Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes

  Not yet reported Hospital de Clinicas de Porto Alegre 20 participants Est. completion 2015-08 1 site
  Type 2 diabetes Other conditions: Hypoglycemic Agents, Diabetic Blood Glucose Monitoring, Exercise
  View official trial listing →
• Terminated NCT NCT01934816

  Incretin and KATP Channels

  Not yet reported Katarina Kos 2 participants Est. completion 2015-10 1 site
  Other conditions: Healthy Subjects
  View official trial listing →
• Completed NCT NCT01940302

  Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes

  Not yet reported Shaoguan University 71 participants Est. completion 2014-03 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT01944618

  forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

  AstraZeneca 5000 participants Est. completion 2015-10 1 site
  Type 2 diabetes
  View official trial listing →
• Withdrawn NCT NCT01947699

  Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide

  Not yet reported University of Pittsburgh Est. completion 2014-09 1 site
  Other conditions: Gestational Diabetes
  View official trial listing →
• Completed NCT NCT01998113

  Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review

  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2509 participants Est. completion 2014-05 1 site
  Other conditions: Gestational Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT02080377

  A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS

  Not yet reported University of Edinburgh 23 participants Est. completion 2016-03 5 sites
  Other conditions: Pregnancy, Gestational Diabetes
  View official trial listing →
• Status unknown NCT NCT02091336

  Oral Antidiabetic Agents in Pregnancy

  Not yet reported Hospital de Clinicas de Porto Alegre 80 participants Est. completion 2016-12 1 site
  Other conditions: Gestational Diabetes
  View official trial listing →
• Completed NCT NCT02128022

  Cardioprotective Effects of GLP-1 and Their Mechanisms

  Not yet reported Papworth Hospital NHS Foundation Trust 32 participants Est. completion 2016-03 1 site Stand-alone
  Other conditions: Angina Pectoris
  View official trial listing →
• Completed NCT NCT02145611

  Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension

  Not yet reported Dr. José Fernando Vilela-Martin MD PhD 50 participants Est. completion 2016-05 1 site
  Type 2 diabetes Other conditions: Hypertension, Endothelial Dysfunction
  View official trial listing →
• Completed NCT NCT02183428

  Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers

  Not yet reported Boehringer Ingelheim 20 participants
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02201602

  Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study

  Not yet reported Khoo Teck Puat Hospital 8 participants Est. completion 2016-07 1 site
  Other conditions: Diabetes
  View official trial listing →
• Status unknown NCT NCT02255006

  Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury

  Not yet reported Kyunghee University Medical Center 36 participants Est. completion 2014-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02297126

  A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

  Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 site
  Other conditions: Adverse Drug Reaction
  View official trial listing →
• Completed NCT NCT02318693

  Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)

  Not yet reported Merck Sharp & Dohme LLC 53 participants Est. completion 2015-12-15
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02375828

  Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels

  Not yet reported Assistance Publique - Hôpitaux de Paris 10 participants Est. completion 2019-07-22 1 site Stand-alone
  Other conditions: Neonatal Diabetes Secondary to Mutation in the Potassium Channel
  View official trial listing →
• Status unknown NCT NCT02406950

  Sitagliptin and Endothelial Dysfunction

  Not yet reported Kyunghee University Medical Center 10 participants Est. completion 2015-08 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT02456428

  Incretin-based Drugs and the Risk of Heart Failure

  Canadian Network for Observational Drug Effect Studies, CNODES 1499650 participants Est. completion 2015-05 1 site
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT02460874

  Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)

  Not yet reported, Not yet reported University of Alabama at Birmingham 1 participants Est. completion 2021-05-19 1 site
  Other conditions: Cerebral Edema, Brain Metastases
  View official trial listing →
• Completed NCT NCT02475499

  Incretin-based Drugs and Pancreatic Cancer

  Canadian Network for Observational Drug Effect Studies, CNODES 886172 participants Est. completion 2015-04 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02476760

  Incretin-based Drugs and Acute Pancreatitis

  Canadian Network for Observational Drug Effect Studies, CNODES 1417914 participants Est. completion 2015-04 1 site
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT02524379

  Spinal Cord Injury Neuroprotection With Glyburide

  Not yet reported, Not yet reported Ohio State University 3 participants Est. completion 2021-02-08 1 site
  Other conditions: Acute Spinal Cord Injury
  View official trial listing →
• Completed NCT NCT02607410

  Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

  Not yet reported University of Sao Paulo General Hospital 40 participants Est. completion 2014-07 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02624817

  Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes

  Not yet reported Haukeland University Hospital 90 participants Est. completion 2016-08 1 site Stand-alone
  Other conditions: Permanent Neonatal Diabetes Mellitus
  View official trial listing →
• Status unknown NCT NCT02624830

  Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)

  Not yet reported Haukeland University Hospital 30 participants Est. completion 2020-02 1 site Stand-alone
  Other conditions: Permanent Neonatal Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT02627898

  Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus

  Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 24 participants Est. completion 2016-12 Stand-alone
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT02726490

  Glyburide vs Glucovance in the Treatment of GDM

  Not yet reported Texas Tech University Health Sciences Center, El Paso 7 participants Est. completion 2018-08-14 1 site
  Other conditions: Gestational Diabetes
  View official trial listing →
• Completed NCT NCT02815787

  The Drug -Drug Interaction of SP2086 and Glyburide

  Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2014-07 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT02830048

  Low dosE GlibENclamide in Diabetes Part A

  Not yet reported University of Oxford 16 participants Est. completion 2017-03-09 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Terminated NCT NCT02864953

  Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

  Not yet reported Remedy Pharmaceuticals, Inc. 535 participants Est. completion 2023-08-18 250 sites
  Cardiovascular disease Other conditions: Brain Edema
  View official trial listing →
• Completed NCT NCT02919345

  Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery

  Not yet reported University of Campinas, Brazil 98 participants Est. completion 2019-03 1 site
  Type 2 diabetesCardiovascular disease Other conditions: Carotid Artery Diseases
  View official trial listing →
• Completed NCT NCT03029702

  Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus

  Not yet reported Maisa N. Feghali, MD 54 participants Est. completion 2023-08-31 1 site
  Other conditions: Gestational Diabetes, Diabetes, Gestational, Pregnancy in Diabetes
  View official trial listing →
• Withdrawn NCT NCT03078725

  Failure Rate of GLyburide And Metformin Among Gestational Diabetics

  Not yet reported The University of Texas Health Science Center, Houston Est. completion 2018-05-10
  Other conditions: Gestational Diabetes Mellitus, Class A2
  View official trial listing →
• Completed NCT NCT03089333

  Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects

  Not yet reported University of Campinas, Brazil 16 participants Est. completion 2017-12 1 site Stand-alone
  Type 2 diabetes Other conditions: Hypertension, Blood Pressure, Obesity, Cardiac Hypertrophy, Microalbuminuria, Vascular Stiffness
  View official trial listing →
• Completed NCT NCT03284463

  Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism

  Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 306 participants Est. completion 2023-05-28 8 sites
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT03492580

  A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

  Janssen Research & Development, LLC 714582 participants Est. completion 2018-06-25 1 site
  Type 2 diabetesCardiovascular disease
  View official trial listing →
• Status unknown NCT NCT03569540

  Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage

  Not yet reported University of Sao Paulo General Hospital 50 participants Est. completion 2019-12-01 1 site Stand-alone
  Other conditions: Subarachnoid Hemorrhage, Aneurysmal
  View official trial listing →
• Completed NCT NCT03741530

  Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage

  Not yet reported Xijing Hospital 220 participants Est. completion 2020-09-23 5 sites Stand-alone
  Other conditions: Intracerebral Hemorrhage
  View official trial listing →
• Completed NCT NCT03855306

  A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. )

  Not yet reported Genuine Research Center, Egypt 27 participants Est. completion 2018-08-15 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03856970

  Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

  Not yet reported Ironwood Pharmaceuticals, Inc. 87 participants Est. completion 2019-07-03 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Status unknown NCT NCT03886922

  The Hemodynamics Effect of Glibenclamide on Levcromakalim Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study With Healthy Volunteers

  Not yet reported Danish Headache Center 15 participants Est. completion 2023-08-30 2 sites
  Other conditions: Hemodynamics of Cranial Arteries, Headache, Cerebral Blood Flow
  View official trial listing →
• Terminated NCT NCT03954041

  A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion

  Not yet reported Remedy Pharmaceuticals, Inc. 92 participants Est. completion 2023-06-27 63 sites
  Other conditions: Brain Contusion
  View official trial listing →
• Completed NCT NCT04231617

  The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers

  Not yet reported Danish Headache Center 20 participants Est. completion 2020-09-01 2 sites
  Other conditions: Hemodynamics of Cranial Arteries, Headache, Cerebral Blood Flow
  View official trial listing →
• Status unknown NCT NCT04239586

  Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes

  Not yet reported Haukeland University Hospital 30 participants Est. completion 2022-04 1 site
  Other conditions: Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1, Childhood Diabetes Mellitus, Insulin-dependent Diabetes Mellitus
  View official trial listing →
• Completed NCT NCT04859452

  A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects

  Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 56 participants Est. completion 2021-07-09 1 site Stand-alone
  Other conditions: Healthy Subjects
  View official trial listing →
• Completed NCT NCT04960657

  The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers

  Not yet reported Danish Headache Center 22 participants Est. completion 2021-03-19 1 site
  Other conditions: Migraine, Headache, Pain
  View official trial listing →
• Status unknown NCT NCT05137678

  Evaluate the Use of Glibenclamide on Acute aSAH

  Not yet reported Beijing Tiantan Hospital 110 participants Est. completion 2022-12-01 1 site Stand-alone
  Other conditions: Subarachnoid Hemorrhage
  View official trial listing →
• Status unknown NCT NCT05148403

  To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI

  Not yet reported, Not yet reported Beijing Tiantan Hospital 76 participants Est. completion 2022-10-01 2 sites Stand-alone
  Other conditions: Traumatic Brain Injury
  View official trial listing →
• Status unknown NCT NCT05161429

  BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

  Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sites
  Type 2 diabetes
  View official trial listing →
• Active, not recruiting NCT NCT05220917

  Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

  Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 site
  Type 2 diabetes Other conditions: Cardiovascular Events, Renal Disease
  View official trial listing →
• Completed NCT NCT05687500

  Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)

  Not yet reported Assistance Publique - Hôpitaux de Paris 35 participants Est. completion 2026-01-08 1 site Stand-alone
  Other conditions: Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction
  View official trial listing →
• Status unknown NCT NCT05688332

  Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients

  Not yet reported University of Zambia 118 participants Est. completion 2024-01
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT05751525

  Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome

  Royal Devon and Exeter NHS Foundation Trust 21 participants Est. completion 2025-12-31 4 sites
  Other conditions: Neurodevelopmental Disorders, Intellectual Disability, Development Delay, ADHD, Autism Spectrum Disorder, Epilepsy
  View official trial listing →
• Withdrawn NCT NCT05910554

  Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis

  Not yet reported University of Maryland, Baltimore Est. completion 2027-09-01
  Other conditions: Sarcoidosis, Pulmonary
  View official trial listing →
• Status unknown NCT NCT06570980

  Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 200 participants Est. completion 2024-08-30 1 site
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT06589141

  Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes

  Not yet reported Assiut University 180 participants Est. completion 2026-06-30
  Other conditions: Gestational Diabetes Mellitus in Pregnancy
  View official trial listing →
• Active, not recruiting NCT NCT06907472

  Diabetes Management for Primary Healthcare Centers.

  Not yet reported University of Abuja 106 participants Est. completion 2026-12-31 2 sites Stand-alone
  Type 2 diabetes
  View official trial listing →
• Not yet recruiting NCT NCT07221799

  OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis

  Not yet reported University of Maryland, Baltimore 10 participants Est. completion 2029-09-01 1 site Stand-alone
  Other conditions: Multiple Sclerosis, Neuropathic Pain
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT05687500

No related coverage yet.